PROTAC BRD9-binding moiety 1
PROTAC BRD9-binding moiety 1 is a compound that binds to BRD9, and used for inhibiting BRD9 activity, based on PROTAC.
Product Specifications
CAS Number
[2097512-23-5]
UNSPSC
12352005
Hazard Statement
H302-H312-H332
Target
Ligands for Target Protein for PROTAC
Type
Reference compound
Related Pathways
PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Target_Protein-binding_moiety_6.html
Solubility
10 mM in DMSO
Smiles
O=C(O)COC1=CC=C(C2=CN(C)C(C3=C2SC(C(NC(CC4)CCS4(=O)=O)=N)=C3)=O)C=C1OC
Molecular Formula
C23H25N3O7S2
Molecular Weight
519.59
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P363-P501
References & Citations
[1]Remillard D, et al. Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands. Angew Chem Int Ed Engl. 2017 May 15;56 (21) :5738-5743.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
H6003-15B-01 100 µg
HIV-1 pol Integrase, Recombinant (Human Immunodeficiency Virus-1)
Ask
View Details H6003-15B-02 1 mg
HIV-1 pol Integrase, Recombinant (Human Immunodeficiency Virus-1)
Ask
View Details 
MBS1068490-01 0.02 mg (E-Coli)
Recombinant Rhodospirillum rubrum ATP synthase gamma chain (atpG)
Ask
View Details